Cargando…
Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway
Senescence frequently occurs in cancer cells in response to chemotherapy (called therapy-induced senescence). Senescent cells can exert paracrine effects through the senescence-associated secretory phenotype (SASP) promoting cancer recurrence and chemoresistance. The altered gut microbiota has been...
Autores principales: | Zhang, Jian-Wei, Zhang, Dan, Yin, Hai-Sen, Zhang, Han, Hong, Kun-Qiao, Yuan, Jing-Ping, Yu, Bao-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078122/ https://www.ncbi.nlm.nih.gov/pubmed/37017266 http://dx.doi.org/10.1080/19490976.2023.2197836 |
Ejemplares similares
-
Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
por: Liu, Yang, et al.
Publicado: (2020) -
Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma
por: Li, Yiqiu, et al.
Publicado: (2023) -
Clinical Significance of Fusobacterium nucleatum Infection and Regulatory T Cell Enrichment in Esophageal Squamous Cell Carcinoma
por: Zhang, Ning, et al.
Publicado: (2021) -
Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma
por: Li, Zhen, et al.
Publicado: (2021) -
Fusobacterium nucleatum and cancer
por: Alon‐Maimon, Tamar, et al.
Publicado: (2022)